title: [Features of the course of silent myocardial ischemia and choice of therapeutic policy].
authors.forename: A L
authors.initials: AL
authors.lastname: Syrkin
authors.forename: A B
authors.initials: AB
authors.lastname: Smulevich
authors.forename: D V
authors.initials: DV
authors.lastname: Drozdov
authors.forename: M Iu
authors.initials: MIu
authors.lastname: Drobizhev
authors.forename: M B
authors.initials: MB
authors.lastname: Pecherskaia
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000787:Angina Pectoris / Q000175:diagnosis / Q000523:psychology / Q000628:therapy; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D017023:Coronary Angiography; D003937:Diagnosis, Differential; D004562:Electrocardiography; D015716:Electrocardiography, Ambulatory; D005080:Exercise Test; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D009566:Nitrates / Q000627:therapeutic use; D011613:Psychotherapy
chemical_list: D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D009566:Nitrates